石药集团：附属拟出售北京国新汇金30.0704%股权

Core Viewpoint - The company Shiyao Group (01093) announced the sale of a 30.0704% stake in Beijing Guoxin Huijin Co., Ltd. for RMB 230 million, which will allow the company to focus on its core business and optimize its resource allocation and financial structure [1] Group 1 - The seller, Shiyao Innovation Pharmaceutical Co., Ltd., is a non-wholly owned subsidiary of Shiyao Group [1] - The transaction is expected to help the seller concentrate on its core business and reduce operational risks, leading to high-quality development [1] - The target company primarily operates a full-media communication business, which is not part of the seller's core operations [1]